Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.

Current problems in cancer - 1 Jan 2000

Coyne Geraldine O'Sullivan, Takebe Naoko, Chen Alice P

Abstract excerpt

"Precision" trials, using rationally incorporated biomarker targets and molecularly selective anticancer agents, have become of great interest to both patients and their physicians. In the endeavor to test the cornerstone premise of precision oncotherapy, that is, determining if modulating a specific molecular aberration in a patient's tumor with a correspondingly specific therapeutic agent improves clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Clinical Trials as Topic
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Molecular Targeted Therapy

Share to Neoplasms

Share to Precision Medicine

Share to United States

Source

Identifiers

PMID: 28372823
DOI: 10.1016/j.currproblcancer.2017.02.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.PMID 28372823Read ↗

The NCI-MATCH: A National, Collaborative Precision Oncology Trial for Diverse Tumor Histologies.Semantic proximity Read ↗

The Future of Precision Oncology.Semantic proximity Read ↗

National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.Semantic proximity Read ↗

A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection.Semantic proximity Read ↗

Precision oncology: lessons learned and challenges for the futureSemantic proximity Read ↗

Enabling Precision Oncology Through Precision DiagnosticsSemantic proximity Read ↗

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trialSemantic proximity Read ↗

Precision cancer medicine: the future is now, only better.Semantic proximity Read ↗

Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.Semantic proximity Read ↗

The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signalling Pathways Is a Means to an EndSemantic proximity Read ↗

Precision Oncology Decision Support: Current Approaches and Strategies for the Future.Semantic proximity Read ↗

From Tissue-Agnostic to N-of-One Therapies: (R)Evolution of the Precision Paradigm.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.